Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Cerus Corporation

Cerus Corporation (CERS) Stock Overview

Explore Cerus Corporation’s financial performance, market position, analyst ratings, and future outlook.

CERS●NASDAQ
HealthcareMedical - Devices
$2.81
$0.04(1.40%)
U.S. Market opens in 64h 57m

Cerus Corporation (CERS)

Meyka AI Score

Z

Key Financials

Market Cap562.3M
P/E Ratio-77.07
EPS (TTM)$-0.05
ROE-0.10%
Fundamental Analysis

AI Price Forecasts

1 Month$3.17
3 Months$3.16
1 Year Target$3.27

CERS Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Cerus Corporation (NASDAQ: CERS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Cerus Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CERS on the NASDAQ shows an RSI of 51.48, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $3.27 for the NASDAQ listing.

Key metrics behind Cerus Corporation's NASDAQ-traded stock include a P/E ratio of -77.07 and a market capitalization of 562.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CERS on the NASDAQ.

Price Performance (NASDAQ: CERS)

1-Day Change
0.72%
5-Day Change
-1.40%
1-Month Change
-9.94%
3-Month Change
2.55%
6-Month Change
16.60%
Year-to-Date (YTD) Change
36.41%
1-Year Change
134.17%
3-Year Change
65.29%
5-Year Change
-53.78%
All-Time (Max) Change
-76.82%

Contact Information

https://www.cerus.com
925 288 6000
1220 Concord Avenue, Concord, CA, 94520

Company Facts

2,680 Employees
IPO DateJan 31, 1997
CountryUS
Actively Trading

Frequently Asked Questions